Skip to main content
OpenTrials
Completed

NCT Number: NCT02995798

The Characteristics of Regional Bone Quality in the Cervical Vertebrae Considering BMD

Data of CT images and the femoral neck BMD were obtained from 99 patients who underwent the cervical CT and BMD simultaneously (the gap of both studies was within 6 months) from April 2009 to December 2014. There were 52 females and 47 males. The mean age was 63.7 year (female: 63.4 years, male: 64.1; range 32-86 years). The patient was excluded who had any destructive pathology or severe spondylosis in the cervical pedicle and the cervical lateral mass. Patients were divided into three groups according to femoral neck BMD (Group A, T-score ≥-1; Group B, -2.5<T-score<-1.0; Group C, T-score≤-2.5). Group A had normal BMD patients, Group B had lower normal patients including osteopenic patients and Group C presented osteoporotic patients. The mean HU numbers of cortical bone area in the vertebral canal (cHU, the medial wall of the lateral mass), the posterior wall of transverse foramen (fHU), the medial (mHU), lateral wall (lHU) and trabecular area of pedicle (pHU) were measured on the axial CT images in clinical images.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Moon-Kyu Kim

Gangneung, Kangwondo, 25440, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who underwent the cervical CT and BMD simultaneously (the gap of both studies was within 6 months)

Exclusion criteria

  • Who had any destructive pathology or severe spondylosis in the cervical pedicle and the cervical lateral mass.

Treatment and study plan

Cortical Bone thickness and Hounsfield unit (HU) numbers

Other

Cortical Bone thickness and Hounsfield unit (HU) numbers considering BMD

Primary outcomes

  1. Cortical bone Thickness

    Time frame: two weeks

  2. HU number

    Time frame: two weeks

Sponsors and collaborators

Lead sponsor

Gangneung Asan Hospital

Other

Collaborators

  • The Catholic University of Korea

Registry information

Important dates

Study start
2009
Primary completion
2014
Study completion
2016
First posted
Dec 16, 2016
Registry last updated
Dec 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.